Vanguard Group’s iSpecimen ISPC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$7.65K Hold
735
﹤0.01% 4325
2025
Q3
$37.9K Buy
+735
New +$34.5K ﹤0.01% 4315
2024
Q3
Sell
-45
Closed -$11.1K 4358
2024
Q2
$11.1K Sell
45
-51
-53% -$12.2K ﹤0.01% 4387
2024
Q1
$17.8K Sell
96
-72
-43% -$25.4K ﹤0.01% 4400
2023
Q4
$67.1K Sell
168
-20
-11% -$8.71K ﹤0.01% 4346
2023
Q3
$93.4K Sell
188
-16
-8% -$14.1K ﹤0.01% 4356
2023
Q2
$233K Hold
204
﹤0.01% 4289
2023
Q1
$218K Sell
204
-1
-0.5% -$1.22K ﹤0.01% 4308
2022
Q4
$225K Hold
205
﹤0.01% 4291
2022
Q3
$270K Buy
205
+128
+166% +$229K ﹤0.01% 4369
2022
Q2
$134K Buy
77
+32
+71% +$78.3K ﹤0.01% 4516
2022
Q1
$194K Sell
45
-68
-60% -$266K ﹤0.01% 4541
2021
Q4
$709K Buy
+113
New +$811K ﹤0.01% 4357

Other funds holding ISPC

Vanguard Group's ISPC Position: Q4 2025 in Review

Vanguard Group held its iSpecimen (ISPC) position steady in Q4 2025 at 735 shares worth $7.65K. The position accounts for ﹤0.01% of the portfolio, ranked #4325.

Vanguard Group first reported a position in ISPC in Q4 2021 and has held it in 13 quarters since. The position peaked at $709K in Q4 2021. 9 funds tracked by Wall St. Rank hold ISPC as of Q4 2025.

  • Vanguard Group held 735 shares of iSpecimen worth $7.65K as of Q4 2025.
  • Vanguard Group left its iSpecimen share count unchanged in Q4 2025.
  • iSpecimen made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #4325 holding.
  • Vanguard Group first reported a position in iSpecimen in Q4 2021 and has held it in 13 quarters since.
  • Vanguard Group's iSpecimen position peaked at $709K in Q4 2021.
  • 9 funds tracked by Wall St. Rank held iSpecimen as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.